Literature DB >> 23217354

MicroRNAs in atherosclerosis.

Ku-Chung Chen1, Suh-Hang Hank Juo.   

Abstract

MicroRNAs are endogenously expressed small noncoding RNAs that regulate gene expression at the post-transcriptional level. MicroRNAs have emerged as key regulators of several physiological and pathophysiological processes in the cardiovascular system. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the development of atherosclerosis and cardiovascular disease, including change in endothelial function, vascular smooth muscle cell proliferation and migration, macrophage function, and foam cell formation. In this review, we summarize the recent data showing the roles of microRNAs in cell studies, studies on atherosclerotic mice, and human studies.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217354     DOI: 10.1016/j.kjms.2012.04.001

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  14 in total

1.  Human coronary heart disease: importance of blood cellular miR-2909 RNomics.

Authors:  Mansi Arora; Deepak Kaul; Yash Paul Sharma
Journal:  Mol Cell Biochem       Date:  2014-03-16       Impact factor: 3.396

2.  Pinolenic acid exhibits anti-inflammatory and anti-atherogenic effects in peripheral blood-derived monocytes from patients with rheumatoid arthritis.

Authors:  Rabaa Takala; Dipak P Ramji; Robert Andrews; You Zhou; Mustafa Farhat; Mohammed Elmajee; Shelley Rundle; Ernest Choy
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

Review 3.  Decoding microRNA drivers in atherosclerosis.

Authors:  Tanwi Vartak; Soundharya Kumaresan; Eoin Brennan
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

4.  Maternal-fetal genetic interactions, imprinting, and risk of placental abruption.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Bizu Gelaye; Mahlet G Tadesse; Sixto E Sanchez; Fasil Tekola-Ayele; Anjum Hajat; Timothy A Thornton; Cande V Ananth; Michelle A Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2020-09-24

5.  Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Authors:  Yi-Chu Liao; Ping-Yen Liu; Hsiu-Fen Lin; Wen-Yi Lin; James K Liao; Suh-Hang H Juo
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

6.  MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A.

Authors:  Yudong Zhang; Bainan Chen; Liu Ming; Hongsong Qin; Liu Zheng; Zhang Yue; Zhixin Cheng; Yannan Wang; Dawei Zhang; Chunmei Liu; Wang Bin; Qingzhi Hao; Fuchen Song; Bo Ji
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions.

Authors:  Shengya Tian; Yang Cao; Jinliang Wang; Yongjun Bi; Jingquan Zhong; Xiangbin Meng; Wenyu Sun; Ruixue Yang; Luping Gan; Xuping Wang; Hongshi Li; Rong Wang
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

8.  Foxc2 Alleviates Ox-LDL-Induced Lipid Accumulation, Inflammation, and Apoptosis of Macrophage via Regulating the Expression of Angptl2.

Authors:  Liu Yang; Tie Li; Lihuang Zha
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657

9.  Circulating microRNAs have a sex-specific association with metabolic syndrome.

Authors:  Yu-Ting Wang; Pei-Chien Tsai; Yi-Chu Liao; Chung-Y Hsu; Suh-Hang Hank Juo
Journal:  J Biomed Sci       Date:  2013-10-04       Impact factor: 8.410

10.  miR-26a inhibits atherosclerosis progression by targeting TRPC3.

Authors:  Min Feng; Daqian Xu; Lirui Wang
Journal:  Cell Biosci       Date:  2018-01-19       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.